BG62258B1 - Нова кристална модификация на cdch, метод за получаването муи фармацевтични препарати, които го съдържат - Google Patents

Нова кристална модификация на cdch, метод за получаването муи фармацевтични препарати, които го съдържат Download PDF

Info

Publication number
BG62258B1
BG62258B1 BG101043A BG10104396A BG62258B1 BG 62258 B1 BG62258 B1 BG 62258B1 BG 101043 A BG101043 A BG 101043A BG 10104396 A BG10104396 A BG 10104396A BG 62258 B1 BG62258 B1 BG 62258B1
Authority
BG
Bulgaria
Prior art keywords
cdch
monohydrate
water
anhydrous
preparation
Prior art date
Application number
BG101043A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101043A (en
Inventor
Alfons Grunenberg
Patrick Bosche
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG62258(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG101043A publication Critical patent/BG101043A/xx
Publication of BG62258B1 publication Critical patent/BG62258B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG101043A 1995-12-12 1996-12-10 Нова кристална модификация на cdch, метод за получаването муи фармацевтични препарати, които го съдържат BG62258B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
BG101043A BG101043A (en) 1998-04-30
BG62258B1 true BG62258B1 (bg) 1999-06-30

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101043A BG62258B1 (bg) 1995-12-12 1996-12-10 Нова кристална модификация на cdch, метод за получаването муи фармацевтични препарати, които го съдържат

Country Status (42)

Country Link
US (1) US5849752A (cs)
EP (1) EP0780390B1 (cs)
JP (1) JP4104687B2 (cs)
KR (1) KR100525146B1 (cs)
CN (1) CN1061348C (cs)
AR (1) AR005009A1 (cs)
AT (1) ATE221531T1 (cs)
AU (1) AU708006B2 (cs)
BG (1) BG62258B1 (cs)
BR (1) BR9605968A (cs)
CA (1) CA2192418C (cs)
CO (1) CO4480105A1 (cs)
CU (1) CU22774A3 (cs)
CZ (1) CZ288657B6 (cs)
DE (2) DE19546249A1 (cs)
DK (1) DK0780390T3 (cs)
EE (1) EE03474B1 (cs)
ES (1) ES2179910T3 (cs)
HR (1) HRP960558B1 (cs)
HU (1) HU226521B1 (cs)
ID (1) ID22625A (cs)
IL (1) IL119795A (cs)
IN (1) IN185805B (cs)
MA (1) MA24342A1 (cs)
MY (1) MY117492A (cs)
NL (1) NL300109I1 (cs)
NO (1) NO306725B1 (cs)
NZ (1) NZ299905A (cs)
PL (1) PL184885B1 (cs)
PT (1) PT780390E (cs)
RO (1) RO119782B1 (cs)
RU (1) RU2162468C2 (cs)
SA (1) SA96170492B1 (cs)
SG (1) SG47201A1 (cs)
SI (1) SI0780390T1 (cs)
SK (1) SK282805B6 (cs)
SV (1) SV1996000109A (cs)
TR (1) TR199600970A2 (cs)
TW (1) TW411340B (cs)
UA (1) UA35638C2 (cs)
YU (1) YU49485B (cs)
ZA (1) ZA9610405B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000752T2 (tr) * 1997-09-25 2000-09-21 Bayer Aktiengesellschaft Etkin terkibin kontrollü salınımı için ilaç formülü.
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
HU229065B1 (en) 1998-11-10 2013-07-29 Bayer Ip Gmbh Pharmaceutical moxifloxacin compositions
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
EP1562942A1 (en) * 2002-10-31 2005-08-17 Ranbaxy Laboratories, Ltd. Amorphous moxifloxacin hydrochloride
ATE439840T1 (de) * 2003-04-09 2009-09-15 Reddys Lab Ltd Dr Kristalline form iii von wasserfreiem moxifloxacin-hydrochlorid und ein verfahren zu seiner herstellung
US20060264635A1 (en) * 2003-08-05 2006-11-23 Chava Satyanarayana Process for the preparation of moxifloxacin hydrochloride
EP1685130B1 (en) * 2003-11-20 2008-12-10 CHEMI S.p.A. Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
EP2145890B1 (en) 2006-06-27 2012-08-01 Sandoz AG Crystallization of hydrohalides of pharmaceutical compounds
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
KR20150048920A (ko) 2006-11-13 2015-05-07 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
ES2391132T3 (es) * 2008-10-09 2012-11-21 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Uso de disolventes orgánicos en la granulación húmeda de moxifloxacino
US20110212990A1 (en) * 2008-11-06 2011-09-01 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
ES2467105T5 (es) 2008-12-08 2017-12-05 Ratiopharm Gmbh Moxifloxacino compactado
NZ596492A (en) 2009-05-15 2013-08-30 Redx Pharma Ltd Redox drug derivatives
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
US9388178B2 (en) 2012-12-04 2016-07-12 Mankind Research Centre Process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
TWI641372B (zh) 2013-03-15 2018-11-21 美商梅琳塔有限責任公司 使用抗生素治療超重和肥胖患者感染的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
DK164287A (da) * 1986-03-31 1987-10-01 Sankyo Co Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
TW209865B (cs) 1992-01-10 1993-07-21 Bayer Ag
WO1993015070A1 (en) * 1992-01-31 1993-08-05 Chugai Seiyaku Kabushiki Kaisha Crystal of quinolonecarboxylic acid derivative hydrate
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DE69504392T2 (de) * 1994-04-07 1999-02-11 Pfizer Inc., New York, N.Y. Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen

Also Published As

Publication number Publication date
PT780390E (pt) 2002-11-29
EP0780390B1 (de) 2002-07-31
MA24342A1 (fr) 1998-07-01
IL119795A0 (en) 1997-03-18
NO306725B1 (no) 1999-12-13
NO965298D0 (no) 1996-12-11
SG47201A1 (en) 1998-03-20
CA2192418A1 (en) 1997-06-13
SV1996000109A (es) 1997-10-23
NZ299905A (en) 1998-09-24
IL119795A (en) 1998-12-27
SI0780390T1 (en) 2002-10-31
MY117492A (en) 2004-07-31
PL317415A1 (en) 1997-06-23
IN185805B (cs) 2001-05-05
HUP9603428A2 (en) 1997-08-28
US5849752A (en) 1998-12-15
EE03474B1 (et) 2001-08-15
NO965298L (no) 1997-06-13
CN1061348C (zh) 2001-01-31
DE19546249A1 (de) 1997-06-19
AR005009A1 (es) 1999-04-07
BG101043A (en) 1998-04-30
CN1160052A (zh) 1997-09-24
MX9606325A (es) 1997-10-31
ID22625A (id) 1999-12-02
CZ364696A3 (en) 1997-07-16
CA2192418C (en) 2001-06-12
UA35638C2 (uk) 2001-04-16
EP0780390A1 (de) 1997-06-25
ES2179910T3 (es) 2003-02-01
CU22774A3 (es) 2002-07-24
DK0780390T3 (da) 2002-11-11
HRP960558A2 (en) 1998-02-28
CO4480105A1 (es) 1997-07-09
JP4104687B2 (ja) 2008-06-18
PL184885B1 (pl) 2003-01-31
DE59609501D1 (de) 2002-09-05
TR199600970A2 (tr) 1997-06-21
RU2162468C2 (ru) 2001-01-27
KR100525146B1 (ko) 2006-01-27
AU7421696A (en) 1997-06-19
JPH09169757A (ja) 1997-06-30
NL300109I1 (nl) 2003-02-03
SK159196A3 (en) 1997-10-08
ZA9610405B (en) 1997-06-23
HRP960558B1 (en) 2002-04-30
BR9605968A (pt) 1998-08-18
ATE221531T1 (de) 2002-08-15
EE9600201A (et) 1997-06-16
SK282805B6 (sk) 2002-12-03
HUP9603428A3 (en) 1997-10-28
TW411340B (en) 2000-11-11
YU65096A (sh) 1998-12-23
HU9603428D0 (en) 1997-01-28
AU708006B2 (en) 1999-07-29
KR970042550A (ko) 1997-07-24
HU226521B1 (en) 2009-03-30
RO119782B1 (ro) 2005-03-30
CZ288657B6 (cs) 2001-08-15
YU49485B (sh) 2006-08-17
SA96170492B1 (ar) 2006-05-23

Similar Documents

Publication Publication Date Title
BG62258B1 (bg) Нова кристална модификация на cdch, метод за получаването муи фармацевтични препарати, които го съдържат
ES3025633T3 (en) New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer
US10150770B2 (en) Crystal form of bisulfate of JAK inhibitor and preparation method therefor
US20230028566A1 (en) Crystalline Form of a 7H-Benzo[7]Annulene-2-Carboxylic Acid Derivative
KR20210102497A (ko) 피리디노일피페리딘 5-ht1f 작용제에 관한 조성물 및 방법
JP3317649B2 (ja) 結晶形態のカルバペネム化合物
JP2024530315A (ja) Ｂｃｌ－２阻害剤の固体形態、それらの調製方法及び使用方法
CA2452253C (en) Novel crystal of arylethenesulfonamide derivative and preparation process thereof
EP3853200B1 (en) Erbumine salt of treprostinil
KR102858471B1 (ko) Lta4h 저해제의 결정질 형태
BG65240B1 (bg) Кристална полиморфна форма на азабицикло (2,2,2) октан-3-амин цитрат и фармацевтичен състав, който я съдържа, метод за получаване и използването
CA2101571A1 (en) Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
HK1002006B (en) Crystalline modification of cdch, process for its preparation and pharmaceutical compositions containing it
HK1002006A (en) Crystalline modification of cdch, process for its preparation and pharmaceutical compositions containing it
WO2000073303A1 (en) Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
MXPA96006325A (en) New variante cristalina del cdch, procedure for its production and pharmaceutical preparations that contains it
KR940005918B1 (ko) 결정성 데옥시스퍼구알린 삼염산염 및 그의 제조방법
EP3517529A1 (en) Salt of quinazoline derivative, preparation method therefor and application thereof